Transfusion-associated graft-versus-host disease

Transfusion and Apheresis Science

Volumn 49, Issue 2, 2013, Pages 331-333

  Sunul, Hasibe ^a   Erguven, Nedret ^a  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Fatal; Graft versus host disease; Transfusion

Indexed keywords

CIPROFLOXACIN; FLUCONAZOLE; HYPERTENSIVE AGENT; INOTROPIC AGENT; MEROPENEM; METHYLPREDNISOLONE; TEICOPLANIN; VANCOMYCIN;

ADD ON THERAPY; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIABETIC PATIENT; DISEASE COURSE; ELECTROCARDIOGRAM; FEVER; GRAFT INFECTION; HUMAN; INSULIN INFUSION; LABORATORY TEST; LIVER DYSFUNCTION; MALE; PANCYTOPENIA; PHYSICAL EXAMINATION; PUNCH BIOPSY; RASH; SKIN BIOPSY; THORAX RADIOGRAPHY; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; TREATMENT OUTCOME;

FATAL; GRAFT VERSUS HOST DISEASE; TRANSFUSION;

AGED; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; DIABETES MELLITUS; FATAL OUTCOME; GRAFT VS HOST DISEASE; HUMANS; MALE;

EID: 84886640746     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.07.001     Document Type: Article

References (15)

1. Tipu H.N., Ahmed T.A., Khalilullah, Ahmed S., Satti T., Ahmed P. Transfusion associated graft versus host disease. J Pak Med Assoc 2008, 5:143-145.
2. Triulzi D., Duquesnoy R., Nichols L., Clark K., Jukic D., Zeevi A., et al. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Transfusion 2006, 46:885-888.
3. Aoun E., Shamseddine A., Chehal A., Obeid M., Taher A. Transfusion associated GVHD: 10years' experience at the American University of Beirut Medical Center. Transfusion 2003, 43:1672-1676.
4. Hutchinson K., Kopko P.M., Muto K.N., Tuscano J., O'Donnell R.T., Holland P.V., et al. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation. Transfusion 2002, 42:1567-1572.
5. Utter G.H., Lee T.H., Rivers R.M., Montalvo L., Wen L., Chafets D.M., et al. Microchimerism decades after transfusion among combat-injured US veterans from the Vietnam, Korean, and World War II conflicts. Transfusion 2008, 48:1609-1615.
6. Patel K.K., Patel A.K., Ranjan R.R., Shah A.P. Transfusion associated graft versus host disease following whole blood transfusion from an unrelated donor in an immunocompetent patient. Indian J Hematol Blood Transfus 2010, 26:92-95.
7. Takahashi K., Juji T., Miyamoto M., Uchida S., Akaza T., Tadokoro K., et al. Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group. Lancet 1994, 343:700-702.
8. Leitman S.F., Tisdale J.F., Bolan C.D., Popovsky M.A., Klippel J.H., Balow J.E., et al. Transfusion associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus. Transfusion 2003, 43:1667-1671.
9. Butcher S.K., Lord J.M. Stress responses and innate immunity: aging as a contributory factor. Aging Cell 2004, 3:151-160.
10. Alter H.J., Klein H.G. The hazards of blood transfusion in historical perspective. Blood 2008, 112:2617-2626.
11. Dwyre D.M., Holland P.V. Transfusion-associated graft-versushost disease. Vox Sang 2008, 95:85-93.
12. Agbaht K., Altinas N.D., Topeli A., Gohoz O., Ozlebe O. Transfusion associated graft-versus-host disease in immunocompetent patients: case series and review of literature. Transfusion 2007, 47:1405-1411.
13. Wagner F.F., Flegel W.A. Transfusion-associated graft versus host disease: risk due to homozygous HLA haplotypes. Transfusion 1995, 35:284-291.
14. Warren L.J., Simmer K., Roxby D., Grist S., Seshadri R., Morley A. DNA polymorphism analysis in transfusion-associated graft-versus-host disease. J Paediatr Child Health 1999, 35:98-101.
15. Higgins M.J., Blackall D.P. Transfusion-associated graft-versus-host disease: a serious residual risk of blood transfusion. Curr Hematol Rep 2005, 4:470-476.